Intended for healthcare professionals

CCBYNC Open access

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis

BMJ 2011; 342 doi: (Published 26 April 2011) Cite this as: BMJ 2011;342:d2202

Clarification on discount rate used in analysis

The authors would like to clarify that all costs and outcomes
reported in the paper were discounted in the analysis at 3.5% in line with
NICE recommendations. The paper makes this explicit for cost data but
failed to make this explicit for the outcomes reported in QALYs.

Competing interests: Lead and last author

06 October 2011
Tracy E. Roberts
Professor of Health Economics
Pelham Barton
University of Birmingham